Literature DB >> 17587711

Effects of gender on prognosis of patients with known or suspected coronary artery disease undergoing contrast-enhanced dobutamine stress echocardiography.

Ryotaro Wake1, Masaaki Takeuchi, Junichi Yoshikawa, Minoru Yoshiyama.   

Abstract

BACKGROUND: Gender differences in the predictors of outcome among patients with known or suspected coronary artery disease (CAD) undergoing contrast-enhanced dobutamine stress echocardiography (CE-DSE) have not been completely determined. METHODS AND
RESULTS: Follow-up (30+/-17 months) data for 581 men and 309 women with known or suspected CAD who underwent CE-DSE (mean age: 66 years) were obtained. Hard cardiac events included cardiac death and nonfatal myocardial infarction. Total cardiac events included hard cardiac events, unstable angina, congestive heart failure, and late revascularization (>3 months). Cardiac events occurred in 123 male and 50 female patients. Positive results for CE-DSE were associated with worse prognosis in both men and women (2-year total event free rate: 73.5% vs 88.2% in men, p<0.0001, 80.3% vs 91.3% in women, p<0.01). Addition of CE-DSE results, including abnormal left ventricular end-systolic volume response and left ventricular ejection fraction at peak stress <50%, to the clinical and rest echocardiography model provided incremental information for predicting total cardiac events (increase in chi-square value for the model from 60 to 72, p<0.001) in men and (increase in chi-square value for the model from 17 to 32, p<0.001) in women.
CONCLUSIONS: CE-DSE provides incremental information for predicting future cardiac events in both men and women.

Entities:  

Mesh:

Year:  2007        PMID: 17587711     DOI: 10.1253/circj.71.1060

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  1 in total

1.  Gender-and lesion number-dependent difference in "atherogenic index of plasma" in Chinese people with coronary heart disease.

Authors:  Wei Ni; Zhenyu Zhou; Tao Liu; Haoyu Wang; Jianping Deng; Xiaoyan Liu; Guoqiang Xing
Journal:  Sci Rep       Date:  2017-10-16       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.